Fetal interrupted aortik ark tip B’nin antenatal değerlendirilmesi

Volume: 42 Number: 2 July 9, 2015
  • Ali Babacan
  • Yaşam Akpak
  • Okan Özden
  • Selami Süleymanoğlu
  • Ersin Öztürk
  • Ercüment Müngen
EN TR

-

Abstract

Interruption of the aortic arch (IAA) is a rare, severe form of congenital heart defect characterized by complete anatomical discontinuity between two adjacent segments of the aortic arch. The data on the features and outcomes of fetal IAA are limited. Three anatomical types have been described according to the site of interruption. The current recommendations for screening on the obstetric fetal anomaly scan include identification of a 4-chamber view, all 4 valves, and the outflow tracts, all of which can appear to be normal to the ultrasonographer in fetuses with conotruncal anomalies. Although the identification of IAA on a prenatal echocardiogram can be challenging, a number of anatomic features can facilitate the diagnosis. We aim to present the features and outcome of a case of IAA type B referred to our centre in the light of literatures

Keywords

References

  1. Vogel M, Vernon MM, McElhinney DB, et al. Fetal diagnosis
  2. of interrupted aortic arch. Am J Cardiol 2010;105:727-734.
  3. Axt-Fliedner R, Kawecki A, Enzensberger C, et al. Fetal and
  4. neonatal diagnosis of interrupted aortic arch: associations
  5. and outcomes. Fetal Diagn Ther 2011;30:299-305.
  6. Volpe P, Tuo G, De Robertis V, et al. Fetal interrupted aortic
  7. arch: 2D-4D echocardiography, associations and outcome.
  8. Ultrasound Obstet Gynecol 2010;35:302-309.

Details

Primary Language

English

Subjects

-

Journal Section

-

Authors

Yaşam Akpak This is me

Okan Özden This is me

Selami Süleymanoğlu This is me

Ersin Öztürk This is me

Ercüment Müngen This is me

Publication Date

July 9, 2015

Submission Date

July 9, 2015

Acceptance Date

-

Published in Issue

Year 2015 Volume: 42 Number: 2

APA
Babacan, A., Akpak, Y., Özden, O., Süleymanoğlu, S., Öztürk, E., & Müngen, E. (2015). -. Dicle Medical Journal, 42(2), 245-248. https://doi.org/10.5798/diclemedj.0921.2015.02.0565
AMA
1.Babacan A, Akpak Y, Özden O, Süleymanoğlu S, Öztürk E, Müngen E. -. Dicle Medical Journal. 2015;42(2):245-248. doi:10.5798/diclemedj.0921.2015.02.0565
Chicago
Babacan, Ali, Yaşam Akpak, Okan Özden, Selami Süleymanoğlu, Ersin Öztürk, and Ercüment Müngen. 2015. “-”. Dicle Medical Journal 42 (2): 245-48. https://doi.org/10.5798/diclemedj.0921.2015.02.0565.
EndNote
Babacan A, Akpak Y, Özden O, Süleymanoğlu S, Öztürk E, Müngen E (July 1, 2015) -. Dicle Medical Journal 42 2 245–248.
IEEE
[1]A. Babacan, Y. Akpak, O. Özden, S. Süleymanoğlu, E. Öztürk, and E. Müngen, “-”, Dicle Medical Journal, vol. 42, no. 2, pp. 245–248, July 2015, doi: 10.5798/diclemedj.0921.2015.02.0565.
ISNAD
Babacan, Ali - Akpak, Yaşam - Özden, Okan - Süleymanoğlu, Selami - Öztürk, Ersin - Müngen, Ercüment. “-”. Dicle Medical Journal 42/2 (July 1, 2015): 245-248. https://doi.org/10.5798/diclemedj.0921.2015.02.0565.
JAMA
1.Babacan A, Akpak Y, Özden O, Süleymanoğlu S, Öztürk E, Müngen E. -. Dicle Medical Journal. 2015;42:245–248.
MLA
Babacan, Ali, et al. “-”. Dicle Medical Journal, vol. 42, no. 2, July 2015, pp. 245-8, doi:10.5798/diclemedj.0921.2015.02.0565.
Vancouver
1.Ali Babacan, Yaşam Akpak, Okan Özden, Selami Süleymanoğlu, Ersin Öztürk, Ercüment Müngen. -. Dicle Medical Journal. 2015 Jul. 1;42(2):245-8. doi:10.5798/diclemedj.0921.2015.02.0565